PRPO Precipio

Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™

Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™
EN
06/10/2020

Underlying

PRPOPrecipio

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Precipio

 PRESS RELEASE
Free
PRPO PRECIPIO

Precipio Announces Q3-2025 Shareholder Update Call

Precipio Announces Q3-2025 Shareholder Update Call Conference Call to be held on November 17th, 2025 at 5:00 PM EST NEW HAVEN, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  , will be hosting its Q3-2025 corporate update call on November 17th, 2025 at 5:00 PM ET. The call will include updates on all of the company’s current core businesses. The conference call may be accessed by calling 800.717.1738. All callers should ask for the Precipio conference call. Listeners interested in submitting questions in advance should email their questions to  and manag...

November 4, 2025 1 EN
 PRESS RELEASE
Free
PRPO PRECIPIO

Precipio Terminates Its ATM

Precipio Terminates Its ATM Management Decision Further Reinforces Commitment to Responsible Capital Management NEW HAVEN, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  , has terminated its ATM (At-The-Market) instrument with investment bank Alliance Global Partners (AGP). “Our Company is in a much stronger position today than it was when we entered into this structure. With our elimination of negative cash flow from operations, and our recent increases of our cash balance, we now have confidence that we no longer have to rely on a tool like this for c...

September 2, 2025 1 EN
 PRESS RELEASE
Free
PRPO PRECIPIO

Precipio Announces its Q2-2025 Financial Results

Precipio Announces its Q2-2025 Financial Results Conference call to follow tomorrow, August 14 at 5 PM EST NEW HAVEN, Conn., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  , filed its 10-Q report today. The following are the highlights of the Company’s financial performance and outlook for 2025. “Yet another quarter of revenue growth in both company divisions, along with overall gross margin improvement, has led to an improved cash performance for the Company. With the remaining repayment of the Change Healthcare loan to be completed by the end of the year, and...

August 13, 2025 1 EN
 PRESS RELEASE
Free
PRPO PRECIPIO

Precipio Announces Q2-2025 Shareholder Update Call

Precipio Announces Q2-2025 Shareholder Update Call Conference Call to be held on August 14th, 2025 at 5:00 PM EST NEW HAVEN, Conn., July 31, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  , will be hosting its Q2-2025 corporate update call on August 14th, 2025 at 5:00 PM ET. The call will include updates on all of the company’s current core businesses. The conference call may be accessed by calling 800.717.1738. All callers should ask for the Precipio conference call. Listeners interested in submitting questions in advance should email their questions to  and managemen...

July 31, 2025 1 EN
 PRESS RELEASE
Free
PRPO PRECIPIO

Precipio Enters Into Agreement With Warrant Holder To Exercise Majorit...

Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company   has entered into an agreement with its largest warrant holder, amending the existing structure from cash exercise of warrants, to a revised structure whereby 100,000 warrants (approximately ⅓) shall be exercised with cash, and the remainder (approximately 200,000 warrants) to be exercised in a cashless manner. The transaction accomplishes two things: Reducing the number of shares that will be added to t...

July 11, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch